Journal
JOURNAL OF FUNCTIONAL FOODS
Volume 86, Issue -, Pages -Publisher
ELSEVIER
DOI: 10.1016/j.jff.2021.104684
Keywords
Aspalathus linearis; Rooibos; ACE inhibitor; Cardiovascular disease; Diabetes; Inflammation
Categories
Funding
- Cape Peninsula University of Technology
Ask authors/readers for more resources
Rooibos, a herbal tea consumed for centuries, has potent health benefits such as anti-inflammatory and antioxidant properties. This article explores how Rooibos could potentially support general health during the COVID-19 pandemic by modulating the risk of associated comorbidities.
This article presents the potential health benefits of Rooibos to be considered a support during the COVID-19 pandemic. The recent pandemic of COVID-19 has led to severe morbidity and mortality. The highly infectious SARS-CoV-2 is known to prime a cytokine storm in patients and progression to acute lung injury/acute respiratory distress syndrome. Based on clinical features, the pathology of acute respiratory disorder induced by SARS-CoV-2 suggests that excessive inflammation, oxidative stress, and dysregulation of the renin angiotensin system are likely contributors to the COVID-19 disease. Rooibos, a well-known herbal tea, consumed for centuries, has displayed potent anti-inflammatory, antioxidant, redox modulating, anti-diabetic, anti-cancer, cardiometabolic support and organoprotective potential. This article describes how Rooibos can potentially play a supportive role by modulating the risk of some of the comorbidities associated with COVID-19 in order to promote general health during infections.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available